Canaccord Reiterates Buy Rating on AngioDynamics (ANGO)

October 9, 2026 7:06 AM EDT Send to a Friend
Canaccord analyst William Plovanic reiterated a Buy rating and $20.00 price target on AngioDynamics (NASDAQ: ANGO).The analyst commented: "We see ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login